ANDA Review: What You Need to Know About Generic Drug Approval

When you pick up a generic pill at the pharmacy, you might not think about the ANDA review, the formal process the U.S. Food and Drug Administration uses to approve generic versions of brand-name drugs. Also known as the Abbreviated New Drug Application, it’s the legal and scientific gatekeeper that makes sure your $5 generic version of a $100 brand drug works just as well—and is just as safe. This isn’t a shortcut. It’s a rigorous system built on science, not savings.

The Hatch-Waxman Act, a 1984 law that balanced innovation with access. Also known as Drug Price Competition and Patent Term Restoration Act, it created the ANDA pathway to let generic makers skip expensive animal and human trials. Instead, they prove bioequivalence, the exact match in how fast and how much of the drug enters your bloodstream. Also known as AB-rated, this is the golden standard. If your generic delivers the same amount of medicine into your body at the same speed as the brand, the FDA says it’s interchangeable. No guesswork. No compromise.

That’s why a generic metformin works the same for diabetes as Glucophage. Why a generic lisinopril lowers blood pressure just like Prinivil. The ANDA review doesn’t care about the pill’s color, shape, or brand name—it cares about what happens inside you. The process includes strict manufacturing checks, ingredient sourcing, and stability testing. Counterfeit drugs don’t pass. Substandard batches get rejected. The system isn’t perfect, but it’s designed to stop bad products before they reach you.

Behind every approved generic is a mountain of data: dissolution rates, pharmacokinetic studies, batch consistency logs. The FDA doesn’t just sign off—they audit factories, inspect labs, and compare real-world performance. And because these drugs don’t need to repeat costly clinical trials, the savings pass straight to you—often 80% to 85% less than the brand. That’s not cutting corners. That’s smart science.

You’ll find posts here that dig into how this approval system connects to real-world issues: why some people still distrust generics, how supply chain rules like DSCSA protect these same drugs from fakes, and how side effects like vitamin B12 deficiency from metformin are tracked even after approval. Whether you’re a patient wondering if your generic is safe, a caregiver checking dosing, or just someone trying to understand why your prescription costs less now, the ANDA review is the quiet engine behind every affordable pill on your shelf.

FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained
19 November 2025

FDA Office of Generic Drugs: Role, Responsibilities, and Structure Explained

The FDA's Office of Generic Drugs ensures safe, affordable generic medications reach patients by reviewing applications, enforcing bioequivalence standards, and managing regulatory policy under GDUFA and the Hatch-Waxman Act.

Read More